Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
Critical Reviews™ in Eukaryotic Gene Expression
Facteur d'impact: 1.841 Facteur d'impact sur 5 ans: 1.927 SJR: 0.627 SNIP: 0.516 CiteScore™: 1.96

ISSN Imprimer: 1045-4403
ISSN En ligne: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.v15.i2.20
pages 103-114

Rho Proteins in Cell Migration and Metastasis

Brian Titus
Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA
Martin A. Schwartz
Department of Microbiology, Department of Biomedical Engineering, University of Virginia, Charlottesville, VA
Dan Theodorescu
Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA; Department of Pharmacology, University of Colorado, Denver, Colorado; Department of Surgery (Urology), University of Colorado, Denver, Colorado; University of Colorado Comprehensive Cancer Center, Denver, Colorado

RÉSUMÉ

The ability of tumors to invade, colonize, and destroy distant organs was first recognized by Jean-Claude Recamier in 1829. He termed this phenomenon metastasis.1,2 Since it was first described, metastasis has been shown to be a complex multistep process.3 One important step is cell migration—a critical component of both cancer-cell invasion at the primary site (allowing cells to gain access to the vasculature) and for cells to penetrate the host tissue at distant sites.4 The aim of this review is to examine the fundamental role of migration in cancer progression and to discuss the role of the Rho family of small G proteins and their effectors in this process.


Articles with similar content:

Epigenetic/Genetic Mismatch: Using Transdifferentiation as a Potential Cancer Therapy to Exploit the Cell Type Specificity of Cancer
Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 5-6
Devasis Chatterjee, Andrew R. Mendelsohn, Jennifer L. Lei
Cell Death Induction in Cancer Therapy − Past, Present, and Future
Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 3-4
Marc-Eric Halatsch, Sebastian Hasslacher, Klaus-Michael Debatin, Oliver Brühl, Julia Zimmermann, Katia La Ferla-Brühl, Lisa Nonnenmacher, Timo Burster, Mike-Andrew Westhoff, Sara E. Barry, Markus D. Siegelin, Georg Karpel-Massler
Resistance to Cell Death and Its Modulation in Cancer Stem Cells
Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 3-4
Ahmad R. Safa
Endothelial Responses to Bacterial Toxins in Sepsis
Critical Reviews™ in Immunology, Vol.23, 2003, issue 4
Friedrich Grimminger, Ulrich Grandel
Raf Kinase Inhibitory Protein (RKIP): Functional Pleiotropy in the Mammalian Brain
Critical Reviews™ in Oncogenesis, Vol.19, 2014, issue 6
Lucia Mendoza-Viveros, Hai-Ying M. Cheng, Harrod H. Ling, Neel Mehta